CompletedEarly Phase 1NCT05811377

Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability Assay

Studying Interstitial cystitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Christopher J Chermansky, MD
Principal Investigator
Christopher Chermansky, MD
University of Pittsburgh
Intervention
Ferumoxytol(drug)
Enrollment
8 enrolled
Eligibility
18-80 years · All sexes
Timeline
20232025

Study locations (1)

Collaborators

Lipella Pharmaceuticals, Inc. · National Institutes of Health (NIH)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05811377 on ClinicalTrials.gov

Other trials for Interstitial cystitis

Additional recruiting or active studies for the same condition.

See all trials for Interstitial cystitis

← Back to all trials